What antibiotics should be used as empiric therapy for a 48‑day‑old preterm infant (born at 29 weeks + 6 days, corrected gestational age 36 weeks) with fever and cerebrospinal fluid findings suggestive of infection?

Empiric Antibiotic Therapy for Suspected Meningitis in a 48-Day-Old Preterm Infant

For a 48-day-old preterm infant with CSF findings suggestive of bacterial meningitis, initiate IV ampicillin 300 mg/kg/day divided every 6 hours PLUS IV ceftazidime 150 mg/kg/day divided every 8 hours immediately. 1

Age-Specific Antibiotic Selection

This infant falls into the critical 29-60 day age bracket where antibiotic selection differs from younger neonates. According to the 2021 AAP guidelines, infants aged 29-60 days with bacterial meningitis have two acceptable regimens 1:

• Ceftriaxone 100 mg/kg/day (once daily or divided every 12 hours) OR Ceftazidime 150 mg/kg/day (divided every 8 hours) PLUS Vancomycin 60 mg/kg/day (divided every 8 hours)

However, given this infant's preterm status (born at 29+6 weeks, corrected age 36 weeks), the ampicillin-ceftazidime combination is more appropriate because:

1. Prematurity increases risk for late-onset Group B Streptococcus (GBS) and Gram-negative organisms including E. coli and other Enterobacteriaceae 2
2. Ampicillin provides essential coverage for GBS and Listeria monocytogenes, which remain significant pathogens in this population 2
3. Ceftazidime offers broader Gram-negative coverage than ceftriaxone, particularly important given the preterm history 1

Critical Dosing Considerations

The meningitis dosing is double the sepsis dosing for ampicillin:

• Meningitis: Ampicillin 300 mg/kg/day divided every 6 hours
• Sepsis without meningitis: Ampicillin 150 mg/kg/day divided every 8 hours 1

This higher dosing achieves adequate CSF penetration necessary for CNS infections.

Vancomycin Consideration

The AAP guideline recommends adding vancomycin for infants 29-60 days old specifically because of resistant Streptococcus pneumoniae 1. However, this recommendation applies primarily to term infants. In preterm infants at 48 days of life:

• If CSF Gram stain shows Gram-positive cocci in chains or pairs, add vancomycin immediately
• If Gram stain shows Gram-negative organisms, consider adding gentamicin (4 mg/kg every 24 hours) for synergy 1
• If Gram stain is negative or unavailable, the ampicillin-ceftazidime combination provides adequate empiric coverage for the most likely pathogens in this preterm population

Aminoglycoside Addition

Some experts recommend adding gentamicin or another aminoglycoside to the regimen, particularly if CSF Gram stain reveals Gram-negative organisms 1. The rationale includes:

• Enhanced bactericidal activity against Gram-negative bacteria
• Synergy with beta-lactams
• Improved outcomes in neonatal Gram-negative meningitis

If adding gentamicin: Use 4 mg/kg IV every 24 hours 1

Pathogen Coverage Rationale

This regimen covers the most critical pathogens for late-onset meningitis in preterm infants:

• GBS: Ampicillin (primary coverage)
• Listeria monocytogenes: Ampicillin (only beta-lactam with reliable activity)
• E. coli and Enterobacteriaceae: Ceftazidime
• Coagulase-negative staphylococci: Partially covered, but vancomycin needed if suspected
• S. pneumoniae: Ceftazidime (vancomycin if resistant strain suspected)

Research data shows that ampicillin-gentamicin combinations provide effective coverage for >94% of early-onset infections 3, and the addition of ceftazidime extends this to late-onset and CNS infections.

Common Pitfalls to Avoid

1. Do NOT use ceftriaxone monotherapy - provides inadequate coverage for GBS and Listeria 1
2. Do NOT use standard sepsis dosing - meningitis requires doubled ampicillin doses for CSF penetration
3. Do NOT delay antibiotics for LP - if LP is delayed or traumatic, treat empirically based on clinical suspicion
4. Do NOT forget to adjust based on local antibiogram - resistance patterns vary by institution 1

Modification Based on Culture Results

Once culture and sensitivity results return:

• Narrow therapy immediately to the most appropriate targeted antibiotic
• Stop vancomycin if organism is not S. pneumoniae, even if susceptibilities are pending 1
• Continue treatment for 14-21 days for Gram-negative meningitis, 14 days for GBS meningitis

Alternative Considerations

The WHO 2024 guidelines suggest ampicillin/amoxicillin/benzylpenicillin plus gentamicin as first-line for neonatal sepsis, with cefotaxime/ceftriaxone as second-line 2. However, for confirmed or suspected meningitis, third-generation cephalosporins are essential for adequate CSF penetration and should be considered first-line rather than second-line therapy.